Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11140%2F12%3A10125835" target="_blank" >RIV/00216208:11140/12:10125835 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11140/12:10125834
Result on the web
<a href="http://ccforum.com/content/pdf/cc11405.pdf" target="_blank" >http://ccforum.com/content/pdf/cc11405.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/cc11405" target="_blank" >10.1186/cc11405</a>

Result language
angličtina
Original language name
Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial
Original language description
Continuous infusion of meropenem is safe, in comparison with higher intermittent dosage provides equal clinical outcome, generates superior bacteriological efficacy and offers encouraging alternative of antimicrobial therapy in critically ill patients.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FP - Other medical fields
OECD FORD branch
—

Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Result description